Medley Therapeutics
TX - HoustonBiotechnology
Focus: Medley Therapeutics is a public biotech company focused on genetic medicines that regenerate tissue and repair organs, primarily in rare diseases. The company operates at a pre-revenue or early-stage commercial phase with limited public visibility.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Medley Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Medley Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Acetylcysteine
Acute Kidney FailureClinical Trials (1)
NCT00736866The Acetylcysteine for Contrast-Induced Nephropathy Trial
Phase 3Help build intelligence for Medley Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.